X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/05/2858555/35057/en/NGM-Bio-Announces-Closing-of-Tender-Offer.html
https://www.globenewswire.com/news-release/2024/03/19/2849009/35057/en/NGM-Bio-to-Present-Two-Posters-Highlighting-Clinical-Data-from-the-Ongoing-Phase-1-2-Clinical-Trial-of-NGM707-a-Dual-ILT2-ILT4-Antagonist-Antibody-Product-Candidate-at-AACR-2024-An.html
https://www.globenewswire.com//news-release/2024/03/11/2844144/35057/en/NGM-Bio-Provides-Recent-Business-Highlights-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.fiercebiotech.com/biotech/ngm-go-private-part-135m-buyout-vc-firm-column-group
https://www.globenewswire.com//news-release/2024/02/26/2835187/35057/en/NGM-Bio-Has-Entered-into-a-Definitive-Agreement-and-Plan-of-Merger-with-Certain-Affiliates-of-The-Column-Group-LP.html
https://www.globenewswire.com//news-release/2024/02/20/2832246/35057/en/NGM-Bio-to-Participate-in-the-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/01/17/2811152/35057/en/NGM-Bio-to-Participate-in-the-B-Riley-Securities-4th-Annual-Oncology-Conference.html
https://www.globenewswire.com//news-release/2024/01/09/2806226/35057/en/NGM-Bio-Announces-New-Clinical-Data-from-Ongoing-Trial-of-NGM707-in-Advanced-Solid-Tumors-and-Outlines-Evolved-Strategy-for-Aldafermin-and-NGM120-to-Focus-on-Rare-Conditions-with-S.html
Market Place
Share 
